Methenamine hippurate 1000 MG Oral Tablet — RxCUI 992150
RxNorm drug concept · Semantic clinical drug
RxCUI 992150
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
14 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI992150
Official nameMethenamine hippurate 1000 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethenamine hippurate 1 GM Oral Tablet
FDA products mapped12
Package NDCs mapped14
Reported Medicaid activity (SDUD)69,581 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Methenamine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- That's a great question. Methenamine isn't used to clear an active infection — it's used to prevent another one from taking hold. Once your other antibiotic has done that job, meth...
- Why do I need to take methenamine if my infection is already gone?
- Yes, it actually does. Methenamine only converts into its active antibacterial form in acidic urine. Foods and medications that make your urine more alkaline — less acidic — can re...
- Does it matter what I eat or drink while I'm on this medication?
🕸️ Concept Web — How Methenamine hippurate 1000 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Methenamine hippurate 1000 MG Oral Tablet
RxCUI 992150 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Methenamine
6832IN -
Methenamine hippurate
29652PIN
-
Methenamine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Hiprex
151856BN -
Urex
220684BN
-
Hiprex
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Methenamine Oral Tablet
372819SCDF -
Methenamine hippurate Oral Tablet
2645478SCDFP -
Methenamine Oral Product
1162215SCDG -
Methenamine Pill
1162216SCDG -
Methenamine hippurate Oral Product
2662954SCDGP -
Methenamine hippurate Pill
2662346SCDGP -
Methenamine Oral Tablet [Hiprex]
368390SBDF -
Methenamine Oral Tablet [Urex]
368389SBDF - +9 more in this family
-
Methenamine Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Methenamine hippurate 1000 MG
992149SCDC -
Methenamine hippurate 1000 MG Oral Tablet [Hiprex]
992152SBD -
Methenamine hippurate 1000 MG Oral Tablet [Urex]
992164SBD -
Methenamine hippurate 1000 MG [Hiprex]
992151SBDC -
Methenamine hippurate 1000 MG [Urex]
992163SBDC
-
Methenamine hippurate 1000 MG
Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Methenamine hippurate 1000 MG
SCDC · 992149 -
Methenamine Oral Tablet
SCDF · 372819 -
Methenamine hippurate Oral Tablet
SCDFP · 2645478 -
Methenamine Oral Product
SCDG · 1162215 -
Methenamine Pill
SCDG · 1162216 -
Methenamine hippurate Oral Product
SCDGP · 2662954 -
Methenamine hippurate Pill
SCDGP · 2662346
Brand-Name Concepts
-
Methenamine hippurate 1000 MG Oral Tablet [Hiprex]
SBD · 992152 -
Methenamine hippurate 1000 MG Oral Tablet [Urex]
SBD · 992164 -
Methenamine hippurate 1000 MG [Hiprex]
SBDC · 992151 -
Methenamine hippurate 1000 MG [Urex]
SBDC · 992163 -
Methenamine Oral Tablet [Hiprex]
SBDF · 368390 -
Methenamine Oral Tablet [Urex]
SBDF · 368389 -
Methenamine hippurate Oral Tablet [Hiprex]
SBDFP · 2658495 -
Methenamine hippurate Oral Tablet [Urex]
SBDFP · 2656815 -
Hiprex Oral Product
SBDG · 1169874 -
Hiprex Pill
SBDG · 1169875
📦 FDA Products & Package NDCs
12 products · 14 package NDCs
14 package NDCs map to RxCUI 992150 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 42571-0332-01 | 100 TABLET in 1 BOTTLE (42571-332-01) | Methenamine Hippurate | Micro Labs Limited | 2019-08-15 |
| 42571-0332-23 | 80 TABLET in 1 CARTON (42571-332-23) | Methenamine Hippurate | Micro Labs Limited | 2019-08-15 |
| 47781-0577-01 | 100 TABLET in 1 BOTTLE (47781-577-01) | Methenamine Hippurate | Alvogen Inc. | 2017-10-23 |
| 50268-0549-15 | 50 BLISTER PACK in 1 CARTON (50268-549-15) / 1 TABLET in 1... | Methenamine Hippurate | AvPAK | 2020-12-02 |
| 50742-0142-01 | 100 TABLET in 1 BOTTLE (50742-142-01) | METHENAMINE HIPPURATE | Ingenus Pharmaceuticals, LLC | 2020-12-18 |
| 51407-0880-01 | 100 TABLET in 1 BOTTLE (51407-880-01) | METHENAMINE HIPPURATE | Golden State Medical Supply, Inc. | 2024-01-30 |
| 59746-0797-01 | 100 TABLET in 1 BOTTLE (59746-797-01) | Methenamine Hippurate | Jubilant Cadista Pharmaceuticals Inc. | 2023-01-24 |
| 59746-0797-65 | 20 TABLET in 1 BOTTLE (59746-797-65) | Methenamine Hippurate | Jubilant Cadista Pharmaceuticals Inc. | 2023-01-24 |
| 60687-0694-21 | 30 BLISTER PACK in 1 CARTON (60687-694-21) / 1 TABLET in 1... | Methenamine Hippurate | American Health Packaging | 2022-08-12 |
| 65862-0782-01 | 100 TABLET in 1 BOTTLE (65862-782-01) | Methenamine Hippurate | Aurobindo Pharma Limited | 2016-07-05 |
| 70685-0050-01 | 100 TABLET in 1 BOTTLE (70685-050-01) | Methenamine Hippurate | Esjay Pharma LLC | 2025-01-16 |
| 70771-1919-01 | 100 TABLET in 1 BOTTLE (70771-1919-1) | Methenamine hippurate | Zydus Lifesciences Limited | 2025-03-12 |
| 72578-0175-01 | 100 TABLET in 1 BOTTLE (72578-175-01) | Methenamine hippurate | Viona Pharmaceuticals Inc | 2025-03-12 |
| 72603-0816-01 | 100 TABLET in 1 BOTTLE (72603-816-01) | Methenamine Hippurate | NorthStar Rx LLC | 2025-04-01 |
Observed labelers:
Jubilant Cadista Pharmaceuticals Inc. (2) ·
Micro Labs Limited (2) ·
Alvogen Inc. (1) ·
American Health Packaging (1) ·
Aurobindo Pharma Limited (1) ·
AvPAK (1)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.